Table 2.

Vaccines coadministered with GSK’s IIV4

GSK IIV4	Coadministered vaccine classa	Belgium [N  = 329]		Germany [N  = 278]		Spain [N  = 453]		Total [N  = 1060]
		n	%	n	%	n	%	n	%
Dose 1	Any	3	0.9	5	1.8	50	11.0	58	5.5
	Bacterial + viral					2	0.4	2	0.2
	Hib					2	0.4	2	0.2
	Hepatitis					21	4.6	21	2.0
	Meningococcal					13	2.9	13	1.2
	Multiple			2	0.7			2	0.2
	Other viral					6	1.3	6	0.6
	Pneumococcal	3	0.9	3	1.1	18	4.0	24	2.3
	Poliomyelitis					1	0.2	1	0.1
	Varicella zoster					1	0.2	1	0.1

						Spain [N  = 139]		Total [N  = 139]
Dose 2	Any					2	1.4	2	1.4
	Hepatitis					1	0.7	1	0.7
	Meningococcal					1	0.7	1	0.7

Hib Haemophilus influenzae B, IIV4 inactivated quadrivalent seasonal influenza vaccine, N number of subjects vaccinated with GSK’s IIV4, n number of subjects with coadministered vaccine

^aVaccination classes coded using the GSK Drug dictionary